Heart Transplant Recipients
10
1
1
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
10.0%
1 terminated out of 10 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
Respiratory Strength Training in Heart Transplant Recipients
Mixing 1:1 HIIT and MICT in Early to Very Early Phase HTx Recipients : a Retrospective Study From a 510 Patients/12 Years Database
High-intensity Interval Training Versus Moderate Continuous Training in Heart Transplant Recipients.
Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
High Intensity Training in de Novo Heart Transplant Recipients in Scandinavia
Autonomic Cardiovascular Control After Heart Transplantation
The GRAFT Study: Evaluation of Graft Function, Rejection and Cardiac Allograft Vasculopathy in First Heart Transplant Recipients.
Long Term Effect of High-intensity Training After Heart Transplantation
Acute Effect of Strength Training on Blood Pressure in Cardiac Patients